We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Siemens Healthineers Showcases Advanced Diagnostics Analyzers

By LabMedica International staff writers
Posted on 07 Feb 2018
Siemens Healthineers (Erlangen, Germany) showcased its Atellica range of advanced diagnostics analyzers at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE.
 
Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. More...
Among the exhibitors at the event was Siemens Healthineers, which displayed its Atellica range of flexible and scalable automation-ready immunoassay and chemistry analyzers, fully-automated high-volume coagulation system, and automated urinalysis system.
 
At MEDLAB Middle East 2018, Siemens exhibited its Atellica Solution, which is designed to address common clinical laboratory challenges and integrates immunoassay and clinical chemistry analyzers with the new standard in sample-management technology so laboratories can focus on driving better outcomes. Also on display was the company’s Atellica COAG 360 System, a fully automated high volume coagulation analyzer that simplifies lab operations by unifying five methodologies on one platform, streamlines hemostasis workflow through intelligent reagent and consumable management, and delivers infinite possibilities by being the first to integrate LOCI technology in specialty hemostasis testing.
 
Siemens also showcased the Atellica 1500 Automated Urinalysis System, which combines the CLINITEK Novus Analyzer and the new Atellica UAS 800 Analyzer. The truly digital automated urinalysis system sets new standards for accuracy and efficiency and allows laboratories to manage more samples with less staff in shorter time without compromising on high-quality results. The company also showcased the Atellica MDX 160 Molecular System, which provides innovation in the molecular laboratory by improving workflow and consolidation while providing for flexibility and customization.
 
Other instruments showcased by Siemens at this year’s MEDLAB Middle East included the Atellica NEPH 630 System, a mid-volume dedicated nephelometric analyzer that simplifies lab operations in specialty protein testing, and the handheld epoc Blood Analysis System which goes wherever patients are located and provides lab-quality results on the spot. Siemens also demonstrated the Atellica PM 1.0 Software, which is the only lab management system that allows the management of laboratory’s processes, including alerts, remote management of instruments, and monitoring of onboard inventory and testing progress—all from one screen.
 

New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Illustration of a cross-section of a blood vessel with red blood cells, white blood cells, and fragments of DNA (Photo Courtesy of UC San Diego/Adobe Firefly)

Microbial DNA Signature in Blood Plasma Differentiates Two Liver Cancer Types

Determining whether a cancerous tumor originated in a given location or spread from another organ is critical for guiding diagnosis and treatment decisions. When the primary tumor site cannot be identified,... Read more

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.